essence study semaglutide In an interim analysis of a phase 3 trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly improved liver histologic results at 72 weeks. Full trial results and Research Semaglutide Improves Histology in MASH:

This mechanism of action differs from that of sulfonylurea derivatives, which stimulate insulin release even at low blood glucose concentrations, which is fraught with the development of sulfonylurea-induced hypoglycemia not only in patients with type 2 diabetes mellitus, but also in healthy individuals

In theory, this could increase the risk for adverse effects and toxicity

Analyses were performed in RStudio version 2023.03.0 + 386 (RStudio: Integrated Development for R)

Generic versions could cut prices significantly making this vital medication more accessible to more people

We want you to know exactly what is going into your body so you can accurately track how you feel and perform

The FDA analyzed data from large clinical trials and real-world studies involving more than 100,000 patients and did not identify higher rates of suicide-related outcomes or serious psychiatric side effects compared to placebo or other diabetes treatments